Neuralink's "Blindsight" device, developed by Elon Musk's company, aims to restore vision for blind individuals.

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain ...

The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.

With the FDA’s breakthrough designation, this cutting-edge technology is quickly advancing through the approval process, underscoring its potential to transform the lives of those living with ...

The device is a variant of Neuralink's brain implant technology, in this case designed to "enable even those who have lost both eyes" to see, according to owner Elon Musk. Separately, progress is ...

Neuralink, a company founded by Elon Musk in 2016, is working on brain chip interfaces aimed at addressing disabilities like ...

"We also extended our leadership in the brain-computer interface realm, adding an FDA Breakthrough Device Designation (our 10 th) and gaining admittance into the FDA's new TAP program to streamline ...

Company continues pioneering research on BCI-enabled system to restore mobility after spinal cord injuryEINDHOVEN, The Netherlands, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ON ...

The US Food and Drug Administration (FDA) granted Abbott Breakthrough Device designation to explore use of DBS for TRD under its Breakthrough Devices Program, which expedites the review of innovative ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. Apple has been slowly making more and more components of its devices in house; a new report ...

Apple has been slowly making more and more components of its devices in house; a new report claims that batteries could soon join the ranks of parts that Apple develops on its own. And those ...